Cancer Cells Resistance Shaping by Tumor Infiltrating Myeloid Cells.

cancer development microenvironment myeloid cells resistance

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
06 Jan 2021
Historique:
received: 30 11 2020
revised: 23 12 2020
accepted: 30 12 2020
entrez: 9 1 2021
pubmed: 10 1 2021
medline: 10 1 2021
Statut: epublish

Résumé

Interactions between malignant cells and neighboring stromal and immune cells profoundly shape cancer progression. New forms of therapies targeting these cells have revolutionized the treatment of cancer. However, in order to specifically address each population, it was essential to identify and understand their individual roles in interaction between malignant cells, and the formation of the tumor microenvironment (TME). In this review, we focus on the myeloid cell compartment, a prominent, and heterogeneous group populating TME, which can initially exert an anti-tumoral effect, but with time actively participate in disease progression. Macrophages, dendritic cells, neutrophils, myeloid-derived suppressor cells, mast cells, eosinophils, and basophils act alone or in concert to shape tumor cells resistance through cellular interaction and/or release of soluble factors favoring survival, proliferation, and migration of tumor cells, but also immune-escape and therapy resistance.

Identifiants

pubmed: 33418996
pii: cancers13020165
doi: 10.3390/cancers13020165
pmc: PMC7825276
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Oncol Lett. 2015 Aug;10(2):754-760
pubmed: 26622565
Cancer Cell. 2017 May 8;31(5):711-723.e4
pubmed: 28486109
Br J Haematol. 2003 Nov;123(3):380-8
pubmed: 14616995
Cancer Res. 2011 Sep 15;71(18):5987-97
pubmed: 21896641
J Neuroinflammation. 2013 Mar 04;10:35
pubmed: 23452918
Sci Rep. 2019 Mar 6;9(1):3715
pubmed: 30842526
J Exp Med. 2001 Aug 20;194(4):541-9
pubmed: 11514609
J Biol Regul Homeost Agents. 2013 Jul-Sep;27(3):827-39
pubmed: 24152847
PLoS One. 2019 Feb 27;14(2):e0212513
pubmed: 30811474
Int J Cancer. 2015 Feb 1;136(3):572-83
pubmed: 24806531
Front Immunol. 2012 Feb 20;3:16
pubmed: 22566901
Science. 2014 May 23;344(6186):921-5
pubmed: 24812208
J Clin Invest. 2014 Dec;124(12):5466-80
pubmed: 25384214
J Exp Med. 1999 Apr 19;189(8):1343-54
pubmed: 10209050
Science. 2011 Mar 25;331(6024):1565-70
pubmed: 21436444
Immunity. 1996 Jan;4(1):15-24
pubmed: 8574848
Cancer Immunol Res. 2018 Nov;6(11):1352-1363
pubmed: 30171135
Front Cell Neurosci. 2019 Sep 18;13:422
pubmed: 31619965
Cancer Sci. 2020 Jan;111(1):47-58
pubmed: 31710162
JCI Insight. 2019 Oct 3;4(19):
pubmed: 31578309
Oncogene. 2015 Mar 5;34(10):1241-52
pubmed: 24662827
Cancer Res. 2006 Jan 15;66(2):1123-31
pubmed: 16424049
Eur J Pharmacol. 2016 May 5;778:68-76
pubmed: 26051792
Cell. 2017 Apr 20;169(3):510-522.e20
pubmed: 28431249
Sci Immunol. 2020 Feb 21;5(44):
pubmed: 32086381
Nat Commun. 2016 Dec 23;7:13720
pubmed: 28008905
Blood. 2010 Jun 17;115(24):4981-90
pubmed: 20233968
Gastroenterology. 2019 Apr;156(5):1467-1482
pubmed: 30550822
Nat Med. 2011 Nov 07;17(11):1381-90
pubmed: 22064428
Sci Rep. 2017 Jan 30;7:41744
pubmed: 28134325
J Immunol. 2000 Nov 15;165(10):5839-46
pubmed: 11067944
Blood. 2013 Feb 28;121(9):e57-69
pubmed: 23293084
Clin Rev Allergy Immunol. 2002 Apr;22(2):107-18
pubmed: 11975418
Nat Immunol. 2005 Feb;6(2):135-42
pubmed: 15662442
J Allergy Clin Immunol. 2011 Jan;127(1):194-9
pubmed: 21211654
Oncotarget. 2016 Nov 26;8(32):52225-52236
pubmed: 28881725
Cancer Biol Med. 2020 Feb 15;17(1):154-168
pubmed: 32296583
Gastroenterology. 2004 Mar;126(3):693-702
pubmed: 14988823
Exp Dermatol. 2020 Oct 26;:
pubmed: 33107136
Cell. 2010 Apr 2;141(1):39-51
pubmed: 20371344
Clin Rev Allergy Immunol. 2018 Jun;54(3):397-411
pubmed: 28725969
J Allergy Clin Immunol. 2018 Jan;141(1):311-321.e10
pubmed: 28624612
J Immunol. 2016 Nov 1;197(9):3445-3453
pubmed: 27683753
Hum Pathol. 2000 Aug;31(8):955-60
pubmed: 10987256
Melanoma Res. 2015 Dec;25(6):479-85
pubmed: 26317168
Nat Immunol. 2018 Jan;19(1):76-84
pubmed: 29180808
Nature. 2015 Mar 12;519(7542):237-41
pubmed: 25517090
Cancer Cell. 2009 Aug 4;16(2):91-102
pubmed: 19647220
Oncogene. 2015 Oct 1;34(40):5175-86
pubmed: 25619830
Cancers (Basel). 2020 Jul 10;12(7):
pubmed: 32664318
J Immunol. 2001 Oct 1;167(7):3565-9
pubmed: 11564767
Nat Med. 2007 Jul;13(7):828-35
pubmed: 17603493
Blood Cancer J. 2016 Jan 15;6:e381
pubmed: 26771807
Sci Rep. 2016 Jul 14;6:29719
pubmed: 27411490
Int Arch Allergy Immunol. 2019;179(4):247-261
pubmed: 31137021
Methods Mol Biol. 2014;1192:193-203
pubmed: 25149494
Sci Rep. 2017 Mar 27;7(1):447
pubmed: 28348370
J Interferon Cytokine Res. 2002 Nov;22(11):1071-80
pubmed: 12513906
Mol Immunol. 2019 Aug;112:72-81
pubmed: 31078118
Nature. 2012 Nov 8;491(7423):254-8
pubmed: 23034650
Inflamm Res. 2018 Sep;67(9):737-746
pubmed: 29909493
Oncoimmunology. 2017 Apr 20;6(6):e1317420
pubmed: 28680750
Oncoimmunology. 2019 Jun 11;8(9):e1624129
pubmed: 31428521
J Exp Clin Cancer Res. 2019 Sep 18;38(1):411
pubmed: 31533774
Blood. 2005 Aug 1;106(3):1012-20
pubmed: 15860672
J Exp Med. 2008 Sep 29;205(10):2235-49
pubmed: 18809714
Cell Tissue Res. 2018 Mar;371(3):531-539
pubmed: 29383445
Nat Immunol. 2018 Aug;19(8):859-870
pubmed: 30013146
JCI Insight. 2019 Mar 7;4(5):
pubmed: 30721157
Int J Cancer. 2016 Apr 15;138(8):1982-93
pubmed: 26619320
Oncoimmunology. 2013 Jan 1;2(1):e22338
pubmed: 23482834
Oncoimmunology. 2019 Jun 11;8(9):e1605822
pubmed: 31428515
Cancer Res. 2010 Jan 1;70(1):99-108
pubmed: 19996287
J Immunother Cancer. 2020 Sep;8(2):
pubmed: 32907925
J Clin Oncol. 2005 Dec 10;23(35):8959-67
pubmed: 16219934
Nat Rev Immunol. 2014 Aug;14(8):571-8
pubmed: 25033907
J Cancer. 2017 Feb 25;8(5):761-773
pubmed: 28382138
Blood. 2000 Jun 1;95(11):3489-97
pubmed: 10828034
Oncoimmunology. 2016 May 24;5(8):e1189052
pubmed: 27622061
Oncotarget. 2016 Oct 18;7(42):68990-69001
pubmed: 27602499
Oncotarget. 2015 Oct 27;6(33):34758-73
pubmed: 26416449
Cell. 2018 Nov 1;175(4):1031-1044.e18
pubmed: 30318149
J Exp Clin Cancer Res. 2016 Sep 02;35(1):131
pubmed: 27589954
Immunol Cell Biol. 2013 Sep;91(8):493-502
pubmed: 23797066
Cancer Immunol Res. 2017 Jul;5(7):535-546
pubmed: 28536100
Immunity. 2003 Jul;19(1):71-82
pubmed: 12871640
Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):E4041-E4050
pubmed: 29632196
Cancer Res. 2016 Jan 15;76(2):239-50
pubmed: 26567141
Cancer Cell. 2012 Mar 20;21(3):309-22
pubmed: 22439926
Immunity. 2018 Jun 19;48(6):1160-1171.e5
pubmed: 29858009
Cells. 2020 Jul 07;9(7):
pubmed: 32645919
J Immunol. 2009 Feb 15;182(4):2432-8
pubmed: 19201898
J Immunol. 2013 Apr 1;190(7):3783-97
pubmed: 23440412
Cancer Immunol Res. 2020 Mar;8(3):368-382
pubmed: 31941671
Int J Mol Sci. 2019 Jan 11;20(2):
pubmed: 30641920
J Exp Med. 2011 Sep 26;208(10):1949-62
pubmed: 21930770
Cancer Immunol Immunother. 2004 Feb;53(2):79-85
pubmed: 14610620
Oncotarget. 2018 Jun 19;9(47):28364-28378
pubmed: 29983866
Transpl Immunol. 1999 Mar;7(1):65-72
pubmed: 10375080
Curr Opin Immunol. 2018 Feb;50:39-47
pubmed: 29144996
Immunity. 2017 Feb 21;46(2):205-219
pubmed: 28190711
PLoS One. 2014 Nov 04;9(11):e111815
pubmed: 25369029
Nature. 2009 Jan 1;457(7225):102-6
pubmed: 19122641
Nat Immunol. 2010 May;11(5):373-84
pubmed: 20404851
Eur J Pharmacol. 2016 May 5;778:2-10
pubmed: 26164789
J Clin Pathol. 2004 Jun;57(6):630-6
pubmed: 15166270
Cancer Res. 2012 Aug 15;72(16):3906-11
pubmed: 22751463
J Immunol. 2001 Apr 15;166(8):4813-7
pubmed: 11290754
Transl Oncol. 2019 Dec;12(12):1549-1556
pubmed: 31493676
Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18105-10
pubmed: 16330751
J Allergy Clin Immunol. 2018 Jun;141(6):2132-2141.e4
pubmed: 28823811
J Leukoc Biol. 2009 Nov;86(5):1065-73
pubmed: 19741157
Front Immunol. 2020 Sep 30;11:552205
pubmed: 33117341
Nat Immunol. 2013 Aug;14(8):821-30
pubmed: 23812096
Front Immunol. 2019 Sep 18;10:2243
pubmed: 31620141
Asia Pac J Clin Oncol. 2018 Oct;14(5):e243-e251
pubmed: 29532611
J Allergy Clin Immunol. 2007 Jun;119(6):1382-7
pubmed: 17337299
Trends Immunol. 2004 Dec;25(12):677-86
pubmed: 15530839
Front Immunol. 2020 Apr 28;11:532
pubmed: 32411122
Blood. 2000 Oct 15;96(8):2655-63
pubmed: 11023495
Blood. 2007 May 15;109(10):4336-42
pubmed: 17244679
Neoplasia. 2012 Jul;14(7):572-84
pubmed: 22904675
Nature. 2018 Feb 22;554(7693):538-543
pubmed: 29443964
Cancer Res. 2010 Oct 1;70(19):7465-75
pubmed: 20841473
Nat Commun. 2020 Aug 11;11(1):4011
pubmed: 32782249
Cancer Med. 2018 Mar;7(3):690-697
pubmed: 29468834
Cancer Immunol Immunother. 2020 Jun;69(6):1113-1130
pubmed: 32114681
Life Sci. 2020 Feb 1;242:117229
pubmed: 31887298
Nature. 2019 Feb;566(7745):553-557
pubmed: 30728496
Cancer Res. 2016 Apr 1;76(7):1792-803
pubmed: 26873846
Nat Immunol. 2016 Jan;17(1):34-40
pubmed: 26681460
Sci Transl Med. 2019 Jul 3;11(499):
pubmed: 31270275
Annu Rev Immunol. 2020 Apr 26;38:49-77
pubmed: 32340580
Cell Mol Immunol. 2015 Nov;12(6):692-9
pubmed: 25418473
Nat Rev Immunol. 2014 Jul;14(7):478-94
pubmed: 24903914
Clin Mol Allergy. 2010 Jul 19;8:10
pubmed: 20642833
Clin Cancer Res. 2019 Apr 1;25(7):2194-2205
pubmed: 30385653
J Pathol. 2012 May;227(1):17-28
pubmed: 22262122
J Exp Clin Cancer Res. 2017 Apr 13;36(1):53
pubmed: 28407783
Front Immunol. 2015 Jun 02;6:260
pubmed: 26082777
Cancer Cell. 2011 Apr 12;19(4):541-55
pubmed: 21481794
Eur J Immunol. 2010 Nov;40(11):2969-75
pubmed: 21061430
J Allergy Clin Immunol. 2013 Aug;132(2):463-9.e3
pubmed: 23582567
Prostate. 2016 May;76(7):624-36
pubmed: 26856684
Oncol Rep. 2018 Feb;39(2):818-826
pubmed: 29251331
Cancer Immunol Res. 2019 Jun;7(6):1025-1035
pubmed: 31043414
Int Rev Immunol. 2014 Nov-Dec;33(6):470-89
pubmed: 24730730
Immunity. 2015 Jun 16;42(6):1130-42
pubmed: 26070484
Eur J Cancer. 2003 Mar;39(5):666-74
pubmed: 12628847
Blood. 2009 Jun 4;113(23):5811-8
pubmed: 19339692
Genes Dev. 2010 Feb 1;24(3):241-55
pubmed: 20080943
J Exp Med. 2009 Jun 8;206(6):1327-37
pubmed: 19451266
Annu Rev Physiol. 2017 Feb 10;79:593-617
pubmed: 27959618
Blood. 2015 Mar 12;125(11):1782-92
pubmed: 25568349
J Invest Dermatol. 2011 Jun;131(6):1322-30
pubmed: 21307877
Front Immunol. 2019 Jun 19;10:1361
pubmed: 31275312
Cell. 2015 Dec 17;163(7):1663-77
pubmed: 26627738
Cancer Immunol Immunother. 2012 Aug;61(8):1155-67
pubmed: 22692756
Blood Cancer J. 2015 Oct 02;5:e355
pubmed: 26430726
J Invest Dermatol. 2019 Jan;139(1):186-194
pubmed: 30009831
Hum Pathol. 2010 May;41(5):697-705
pubmed: 20040391
Nat Immunol. 2019 Nov;20(11):1435-1443
pubmed: 31591569
Cancer Res. 2010 Jan 1;70(1):68-77
pubmed: 20028852
Lung Cancer. 2011 Nov;74(2):188-96
pubmed: 21601305
J Mol Evol. 2002 Nov;55(5):553-62
pubmed: 12399929
Cell Mol Life Sci. 2011 Mar;68(6):965-75
pubmed: 21069421
Immunity. 2009 Oct 16;31(4):665-76
pubmed: 19818652
Nat Med. 2017 Mar 7;23(3):279-287
pubmed: 28267716
Blood. 1989 Nov 15;74(7):2527-34
pubmed: 2478233
Mol Cancer. 2011 Sep 22;10:117
pubmed: 21939504
Cell Rep. 2015 Feb 3;10(4):562-73
pubmed: 25620698
Nat Rev Cancer. 2013 Oct;13(10):739-52
pubmed: 24060865
Nat Neurosci. 2007 Dec;10(12):1538-43
pubmed: 18026097
J Immunol. 2009 Jul 15;183(2):937-44
pubmed: 19553533
Cancer Res. 2010 Jul 15;70(14):6071-82
pubmed: 20610626
J Immunol. 2010 Oct 1;185(7):4206-12
pubmed: 20810987
Front Med (Lausanne). 2017 Jun 12;4:75
pubmed: 28660189
Front Biosci. 2008 Jan 01;13:453-61
pubmed: 17981560
J Immunol. 2006 Nov 15;177(10):7322-31
pubmed: 17082651
JCI Insight. 2019 Mar 7;4(5):
pubmed: 30730851
Circ Res. 2012 Jan 6;110(1):159-73
pubmed: 22223212
Cell. 2014 Dec 4;159(6):1312-26
pubmed: 25480296
Proc Natl Acad Sci U S A. 2019 Jan 2;116(1):199-204
pubmed: 30559191
J Clin Invest. 2020 Jan 2;130(1):389-403
pubmed: 31600172
J Immunol. 2012 Feb 1;188(3):1136-46
pubmed: 22210912
Curr Opin Immunol. 2017 Apr;45:43-51
pubmed: 28192720
Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):11774-9
pubmed: 25071169
Front Oncol. 2020 Feb 07;10:109
pubmed: 32117758
Cell Death Differ. 2020 Nov;27(11):3196-3207
pubmed: 32514047
J Immunol. 2017 Apr 15;198(8):3181-3194
pubmed: 28264968
Carcinogenesis. 2012 May;33(5):949-55
pubmed: 22425643
Lab Invest. 1990 May;62(5):626-34
pubmed: 2342332
Nat Rev Immunol. 2006 Mar;6(3):218-30
pubmed: 16470226
Cancer Cell. 2017 Nov 13;32(5):654-668.e5
pubmed: 29136508
Am J Pathol. 2010 Aug;177(2):1031-41
pubmed: 20616342
Oncol Rep. 2018 Nov;40(5):2558-2572
pubmed: 30132555
Development. 2019 May 2;146(9):
pubmed: 31048317
Front Immunol. 2018 Jun 11;9:1310
pubmed: 29942309
Immunity. 2014 Feb 20;40(2):274-88
pubmed: 24530056
Front Immunol. 2017 Apr 12;8:424
pubmed: 28446910
Oncotarget. 2014 Jul 30;5(14):5350-68
pubmed: 25051364
Front Immunol. 2014 Jan 07;4:482
pubmed: 24432017
Oncoimmunology. 2012 Aug 1;1(5):726-734
pubmed: 22934264
Front Immunol. 2014 Sep 19;5:448
pubmed: 25285096
Immunol Rev. 2014 Nov;262(1):85-95
pubmed: 25319329
Eur J Immunol. 2010 Dec;40(12):3347-57
pubmed: 21110318
J Leukoc Biol. 2017 Aug;102(2):237-251
pubmed: 28606938
Nat Rev Immunol. 2020 Sep 9;:
pubmed: 32908299
Immunity. 2010 Dec 14;33(6):905-16
pubmed: 21145760
Blood. 2009 Dec 3;114(24):4979-88
pubmed: 19805617
J Immunol. 2008 May 15;180(10):6439-46
pubmed: 18453558
J Immunol. 2000 Jun 15;164(12):6166-73
pubmed: 10843666
Cancer Cell. 2018 Jan 8;33(1):60-74.e6
pubmed: 29316433
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1117-1122
pubmed: 28096371
Nat Commun. 2015 Mar 26;6:6673
pubmed: 25809117
Immunology. 2012 Jun;136(2):176-83
pubmed: 22304731
J Clin Invest. 1997 Nov 15;100(10):2552-61
pubmed: 9366570
Nat Immunol. 2012 Sep;13(9):832-42
pubmed: 22842346
PLoS Biol. 2018 May 11;16(5):e2004990
pubmed: 29750788
Nat Rev Immunol. 2010 Jun;10(6):440-52
pubmed: 20498670
Science. 2009 Mar 27;323(5922):1722-5
pubmed: 19264983
Oncotarget. 2018 Nov 20;9(91):36317-36330
pubmed: 30555631
Blood. 2008 Aug 15;112(4):1269-79
pubmed: 18524989
J Clin Invest. 2015 Jun;125(6):2317-34
pubmed: 25915587
Am J Respir Cell Mol Biol. 1997 Jul;17(1):70-7
pubmed: 9224211
Cancer Res. 2012 Aug 15;72(16):3919-27
pubmed: 22751466
Expert Rev Mol Diagn. 2018 Jul;18(7):675-683
pubmed: 29707981
Cancer Res. 2016 May 1;76(9):2552-60
pubmed: 27013192
Prostate. 2009 Jun 15;69(9):976-81
pubmed: 19274666
Allergy. 2010 Feb;65(2):168-74
pubmed: 19804447
Science. 2009 Apr 17;324(5925):392-7
pubmed: 19286519
Nat Commun. 2016 Jul 06;7:12150
pubmed: 27381735
Cancer Lett. 2012 Apr 1;317(1):99-105
pubmed: 22108530
J Exp Med. 2017 Jul 3;214(7):1913-1923
pubmed: 28606987
J Immunol. 1998 Feb 1;160(3):1224-32
pubmed: 9570538
J Clin Invest. 2013 Jul 1;:
pubmed: 23863628
J Leukoc Biol. 2015 Mar;97(3):573-82
pubmed: 25583578
J Immunother Cancer. 2017 Dec 19;5(1):101
pubmed: 29254508
Clin Cancer Res. 2017 Jul 15;23(14):3847-3858
pubmed: 28108544
Nat Neurosci. 2019 May;22(5):729-740
pubmed: 30962630
Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21704-21714
pubmed: 31591235
Blood. 2011 Jan 6;117(1):88-97
pubmed: 20930067
Circulation. 2018 Jul 10;138(2):181-197
pubmed: 29437117
Sci Immunol. 2016 Aug;1(2):
pubmed: 28417112
J Immunol. 2000 Jan 15;164(2):762-7
pubmed: 10623821
J Allergy Clin Immunol. 2013 May;131(5):1400-7.e11
pubmed: 23518141
Cardiovasc Res. 2016 May 1;110(1):51-61
pubmed: 26825554
J Immunol. 2006 May 1;176(9):5637-43
pubmed: 16622033
Front Immunol. 2015 Oct 12;6:523
pubmed: 26528286
Front Physiol. 2014 Jan 30;5:9
pubmed: 24523696
J Clin Invest. 2011 Oct;121(10):4015-29
pubmed: 21911941
J Thorac Oncol. 2016 Oct;11(10):1755-64
pubmed: 27418106
Nature. 2013 Apr 25;496(7446):445-55
pubmed: 23619691
Cancer Cell Int. 2019 Mar 25;19:71
pubmed: 30962765
J Exp Med. 2011 Mar 14;208(3):479-90
pubmed: 21339324
Transl Gastrointest Cancer. 2012 Oct;1(3):215-227
pubmed: 24639917
Immunol Rev. 2016 Sep;273(1):11-28
pubmed: 27558325
Nat Immunol. 2016 Jan;17(1):18-25
pubmed: 26681458
Nature. 2009 Jan 15;457(7227):318-21
pubmed: 19037245
Mol Cell Proteomics. 2013 Aug;12(8):2205-19
pubmed: 23660474
J Immunol. 1986 Mar 15;136(6):2231-9
pubmed: 2419427
Blood. 2020 Jul 9;136(2):199-209
pubmed: 32325491
Oncoimmunology. 2014 Jan 1;3(1):e27402
pubmed: 24701375
Pathol Res Pract. 2018 Sep;214(9):1345-1351
pubmed: 30049511
J Immunol. 2010 Jul 1;185(1):642-52
pubmed: 20530259
Nat Immunol. 2020 May;21(5):555-566
pubmed: 32327756
J Immunol. 2014 Apr 1;192(7):3374-82
pubmed: 24591364
Stem Cells Dev. 2016 May 15;25(10):774-87
pubmed: 26979751
Clin Immunol. 2012 Sep;144(3):250-68
pubmed: 22858650
J Allergy Clin Immunol. 2017 Oct;140(4):1159-1162.e6
pubmed: 28433691
J Leukoc Biol. 2003 Aug;74(2):197-205
pubmed: 12885936
Int J Cancer. 2020 Mar 15;146(6):1730-1740
pubmed: 31840816
J Immunol. 2006 Feb 15;176(4):2238-48
pubmed: 16455980
Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):11060-11065
pubmed: 30301793
Leukemia. 2017 Dec;31(12):2652-2660
pubmed: 28479592
Blood. 1998 Dec 15;92(12):4778-91
pubmed: 9845545
Mod Pathol. 2016 May;29(5):516-27
pubmed: 26916075
Cancer Immunol Immunother. 2020 Dec;69(12):2477-2499
pubmed: 32561967
Eur Respir J. 2000 Jun;15(6):1087-93
pubmed: 10885428
Cell Metab. 2008 Jun;7(6):496-507
pubmed: 18522831
Annu Rev Pharmacol Toxicol. 2011;51:267-88
pubmed: 20887196
Annu Rev Immunol. 2003;21:579-628
pubmed: 12500981
Nat Rev Cancer. 2009 May;9(5):361-71
pubmed: 19343034
Int J Cancer. 2014 Jun 15;134(12):2853-64
pubmed: 24259296
Cell Host Microbe. 2019 Jul 10;26(1):114-122.e8
pubmed: 31278040
Cell. 2015 Sep 10;162(6):1257-70
pubmed: 26343581
Immunol Rev. 2018 Mar;282(1):198-231
pubmed: 29431218
Immunity. 2018 Dec 18;49(6):1148-1161.e7
pubmed: 30552023
Oncoimmunology. 2019 Mar 28;8(6):e1581528
pubmed: 31069149
Cancer Immunol Immunother. 2014 Dec;63(12):1297-306
pubmed: 25186613
Nat Rev Immunol. 2012 Mar 22;12(4):253-68
pubmed: 22437938

Auteurs

Marcin Domagala (M)

Centre de Recherches en Cancérologie de Toulouse, Inserm UMR1037, 31037 Toulouse, France.
Université Toulouse III Paul-Sabatier, 31400 Toulouse, France.
ERL 5294 CNRS, 31037 Toulouse, France.

Chloé Laplagne (C)

Centre de Recherches en Cancérologie de Toulouse, Inserm UMR1037, 31037 Toulouse, France.
Université Toulouse III Paul-Sabatier, 31400 Toulouse, France.
ERL 5294 CNRS, 31037 Toulouse, France.

Edouard Leveque (E)

Centre de Recherches en Cancérologie de Toulouse, Inserm UMR1037, 31037 Toulouse, France.
Université Toulouse III Paul-Sabatier, 31400 Toulouse, France.
ERL 5294 CNRS, 31037 Toulouse, France.

Camille Laurent (C)

Centre de Recherches en Cancérologie de Toulouse, Inserm UMR1037, 31037 Toulouse, France.
Université Toulouse III Paul-Sabatier, 31400 Toulouse, France.
ERL 5294 CNRS, 31037 Toulouse, France.
IUCT-O, 31000 Toulouse, France.

Jean-Jacques Fournié (JJ)

Centre de Recherches en Cancérologie de Toulouse, Inserm UMR1037, 31037 Toulouse, France.
Université Toulouse III Paul-Sabatier, 31400 Toulouse, France.
ERL 5294 CNRS, 31037 Toulouse, France.

Eric Espinosa (E)

Centre de Recherches en Cancérologie de Toulouse, Inserm UMR1037, 31037 Toulouse, France.
Université Toulouse III Paul-Sabatier, 31400 Toulouse, France.
ERL 5294 CNRS, 31037 Toulouse, France.

Mary Poupot (M)

Centre de Recherches en Cancérologie de Toulouse, Inserm UMR1037, 31037 Toulouse, France.
Université Toulouse III Paul-Sabatier, 31400 Toulouse, France.
ERL 5294 CNRS, 31037 Toulouse, France.

Classifications MeSH